Recently, our studies and those of others have shown that p53 inactivation/dysfunction alters the immune landscape of the tumor microenvironment (TME) towards pro-tumor inflammation [25,26,27,28], whereas p53 reactivation or restoration changes the milieu of TME to promote antitumor immunity [29,30,31]. Here, TP53 is linked to neoplasm.